Vasoactive intestinal polypeptide (VIP) is an immunomodulatory neuropeptide widely distributed in neural pathways that regulate micturition. VIP is also an endogenous anti-inflammatory agent that has been suggested for the development of therapies for inflammatory disorders. In the present study, we examined urinary bladder function, hindpaw and pelvic sensitivity in VIP -/-and littermate wildtype controls. We demonstrated increased bladder mass and fewer but larger urine spots on filter paper in VIP -/-mice. Using cystometry in conscious, unrestrained mice, VIP -/-mice exhibited increased void volumes and shorter intercontraction intervals with continuous intravesical infusion of saline. No differences in transepithelial resistance or water permeability were demonstrated between VIP -/-and WT mice; however, an increase in urea permeability was demonstrated in VIP -/-mice. With the induction of bladder inflammation by acute administration of cyclophosphamide (CYP), an exaggerated or prolonged bladder hyperreflexia, hindpaw and pelvic sensitivity were demonstrated in VIP -/-mice. The changes in bladder hyperreflexia and somatic sensitivity in VIP -/-mice may reflect increased expression of neurotrophins and/or or proinflammatory cytokines in the urinary bladder. Thus, these changes may further regulate the neural control of micturition.